BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23102494)

  • 41. Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17α in preeclampsia.
    Lim JH; Kim SY; Kim DJ; Park SY; Han HW; Han JY; Lee SW; Yang JH; Ryu HM
    Pharmacogenet Genomics; 2010 Oct; 20(10):605-10. PubMed ID: 20729792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of vascular endothelial growth factor +936 C/T single-nucleotide polymorphism with pregnancies complicated by small-for-gestational-age babies.
    Andraweera PH; Dekker GA; Thompson SD; Nowak RC; Zhang JV; McCowan LM; North RA; Roberts CT
    Arch Pediatr Adolesc Med; 2011 Dec; 165(12):1123-30. PubMed ID: 22147779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allelic variations in angiogenic pathway genes are associated with preeclampsia.
    Srinivas SK; Morrison AC; Andrela CM; Elovitz MA
    Am J Obstet Gynecol; 2010 May; 202(5):445.e1-11. PubMed ID: 20223440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women.
    Enquobahrie DA; Sanchez SE; Muy-Rivera M; Qiu C; Zhang C; Austin MA; Williams MA
    Gynecol Endocrinol; 2005 Oct; 21(4):211-7. PubMed ID: 16316842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia.
    Molvarec A; Vér A; Fekete A; Rosta K; Derzbach L; Derzsy Z; Karádi I; Rigó J
    Hypertens Res; 2007 Mar; 30(3):205-11. PubMed ID: 17510501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-1 alpha variation is associated with the risk of developing preeclampsia.
    Ghasemi M; Kashani E; Fayyaz A; Attar M; Shahbazi M
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():75-8. PubMed ID: 26254854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
    Li C; Zhan Y; Li GZ; Liu SG
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):342-6. PubMed ID: 22883521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia.
    Chedraui P; Andrade ME; Salazar-Pousada D; Escobar GS; Hidalgo L; Ramirez C; Spaanderman ME; Kramer BW; Gavilanes AW
    Gynecol Endocrinol; 2015 Jul; 31(7):569-72. PubMed ID: 26036716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in the activin A receptor type 2A gene affect the onset time and severity of preeclampsia in the Turkish population.
    Zeybek B; Celik HA; Aydin HH; Askar N
    J Perinat Med; 2013 Jul; 41(4):389-99. PubMed ID: 23633461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia.
    Garza-Veloz I; Castruita-De la Rosa C; Cortes-Flores R; Martinez-Gaytan V; Rivera-Muñoz JE; Garcia-Mayorga EA; Meza-Lamas E; Rojas-Martinez A; Ortiz-Lopez R; Martinez-Fierro ML
    BMC Pregnancy Childbirth; 2011 May; 11():35. PubMed ID: 21575227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.
    Zidi S; Stayoussef M; Gazouani E; Mezlini A; Yacoubi-Loueslati B; Almawi WY
    Cytokine; 2015 Jul; 74(1):108-12. PubMed ID: 25541433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.
    Livingston JC; Chin R; Haddad B; McKinney ET; Ahokas R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1554-7. PubMed ID: 11120527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Association of polymorphisms of VEGF and VEGFR1 pathways related genes and risk of pre-eclampsia].
    Li L; Guo X; Chen B; Gao Z; Liu J; Wang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Aug; 39(8):893-897. PubMed ID: 35929944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss.
    Eller AG; Branch DW; Nelson L; Porter TF; Silver RM
    J Reprod Immunol; 2011 Jan; 88(1):48-52. PubMed ID: 20977975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia.
    Papazoglou D; Galazios G; Koukourakis MI; Panagopoulos I; Kontomanolis EN; Papatheodorou K; Maltezos E
    Mol Hum Reprod; 2004 May; 10(5):321-4. PubMed ID: 14997002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism.
    Rahimi Z; Rahimi Z; Mozafari H; Parsian A
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):174-80. PubMed ID: 22719026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
    Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
    Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of genes involved in the angiogenesis-associated signaling pathway with risk of anterior cruciate ligament rupture.
    Rahim M; Gibbon A; Hobbs H; van der Merwe W; Posthumus M; Collins M; September AV
    J Orthop Res; 2014 Dec; 32(12):1612-8. PubMed ID: 25111568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
    Sun SG; Shen N; Zheng YH; Shang T
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
    Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.